Replimune Group, Inc. (Nasdaq: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced financial results for ...

A widely-adopted JavaScript library has been found carrying a critical vulnerability which could allow threat actors to ...

This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed. Chart does not reflect ...

Find the latest Tvardi Therapeutics, Inc. (TVRD) stock quote, history, news and other vital information to help you with your stock trading and investing.